Why Bulls Remain High on Palantir As It Passes $170
Palantir (PLTR) shares passed $170 after Q2 results. Revenue rose 92.83% to $1.935B, EPS was $0.41 vs $0.346 consensus, and adjusted operating margin expanded to 62%. U.S. commercial revenue grew 149% to $764M, free cash flow was $1.22B, and FY2026 revenue guidance was raised to $8.150-$8.158B. Valuation cited includes trailing P/E 147 and P/S 67.
How this was made
The 30-second read
Why it matters
Traders can use the raised FY2026 guidance range, the U.S. commercial acceleration figure, and the stated 18-month growth target as concrete checkpoints for positioning and risk management.
Market read
A post-earnings valuation debate is anchored to specific Q2 beats, profitability expansion, and guidance lift, with a clear downside trigger if U.S. commercial growth slows.
What to watch
The article flags SBC dilution and government contracts being terminable for convenience, which could pressure future free cash flow and retention even if the quarter looked strong.
Background
The piece frames Palantir’s Q2 as a shift from pure growth to a higher-quality growth-and-profitability profile, using Rule of 40 and margin expansion.
Ticker impact
Palantir reported Q2 revenue up 92.83% to $1.935B, raised FY2026 revenue guidance to $8.150-$8.158B, and expanded adjusted operating margin to 62%.
Near-term upside depends on whether U.S. commercial growth sustains; otherwise the article argues the multiple could compress quickly.
The text provides multiple fresh, decision-relevant datapoints (Q2 results, margin expansion, FCF, and raised guidance) plus a clear risk trigger (U.S. commercial growth target for 18 months).
Market effects
Strength in a “sovereign AI infrastructure” narrative may buoy sentiment toward enterprise AI software names, especially those with government exposure.
Primarily U.S.-centric given the emphasis on U.S. commercial acceleration and U.S. guidance.
Limited direct global read-through beyond broader AI software profitability expectations.
Counterpoint
Despite margin expansion, the valuation metrics cited (very high P/E and P/S) imply little room for any deceleration in U.S. commercial growth or renewal risk.
Key entities
- companyPalantir Technologies
Subject of the article; Q2 results, margin expansion, and raised FY2026 guidance drive the rerating thesis.
- executiveRyan Taylor
CRO quoted describing the quarter as unprecedented but unsurprising, reinforcing management’s confidence.
- executiveAlex Karp
CEO referenced for the 18-month U.S. commercial growth matching current rates target.
